Drug:
Reaction: MYELOSUPPRESSION
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555366 |
CN |
80 | 2 |
Disease risk factor, Infection, Haemorrhage, Myelosuppression, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 2 | 26555464 |
PK |
44 | 2 |
Myelosuppression, |
||||
LINEZOLID, LINEZOLID, CYCLOSERINE, |
||||
| 3 | 26555545 |
PK |
37 | 1 |
Myelosuppression, |
||||
LINEZOLID, LINEZOLID, PRETOMANID, |
||||
| 4 | 26555974 |
JP |
1 | |
Myelosuppression, |
||||
PEMBROLIZUMAB, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 5 | 26556405 |
CN |
16 | 1 |
Myelosuppression, Platelet count decreased, |
||||
VENETOCLAX, DECITABINE, ETOPOSIDE, STERILE WATER FOR INJECTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 6 | 26556430 |
US |
68 | 1 |
Myelosuppression, Rash, |
||||
POMALIDOMIDE, |
||||
| 7 | 26557135 |
CN |
73 | 1 |
Myelosuppression, Off label use, |
||||
OXALIPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 8 | 26557240 |
CN |
68 | 1 |
Myelosuppression, |
||||
PEMBROLIZUMAB, OXALIPLATIN, TRASTUZUMAB, CAPECITABINE, |
||||
| 9 | 26557486 |
CN |
1 | |
Myelosuppression, Decreased appetite, Asthenia, Liver injury, Death, |
||||
TRASTUZUMAB, CISPLATIN, CAPECITABINE, |
||||
| 10 | 26557717 |
51 | 2 | |
Myelosuppression, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 11 | 26557797 |
56 | 2 | |
Myelosuppression, |
||||
TAMOXIFEN CITRATE, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE, |
||||
| 12 | 26557811 |
51 | 2 | |
Myelosuppression, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, DENOSUMAB, |
||||
| 13 | 26557914 |
67 | ||
Serratia bacteraemia, Myelosuppression, Sepsis, Cellulitis, |
||||
DOXORUBICIN, DACARBAZINE, PREDNISONE, DAPSONE GEL, 5%, DAPSONE, DASPONE, |
||||
| 14 | 26558291 |
CN |
3 | 1 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, MERCAPTOPURINE, CYTARABINE, |
||||
| 15 | 26558301 |
CN |
9 | 1 |
Myelosuppression, Infection, Pyrexia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MESNA, MESNA INJECTION, VINCRISTINE SULFATE, CYTARABINE, PREDNISONE, |
||||
| 16 | 26558311 |
CN |
3 | 2 |
Myelosuppression, Pyrexia, Serum amyloid A protein increased, C-reactive protein increased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MESNA, MESNA INJECTION, TOPOTECAN HYDROCHLORIDE, |
||||
| 17 | 26558425 |
CN |
69 | 1 |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, CISPLATIN, CISPLATIN, |
||||
| 18 | 26558767 |
CN |
72 | 2 |
Myelosuppression, |
||||
PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 19 | 26558833 |
52 | 2 | |
Myelosuppression, |
||||
CETUXIMAB, IRINOTECAN HYDROCHLORIDE, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 20 | 26559422 |
CN |
27 | 1 |
Myelosuppression, Back pain, |
||||
FRUQUINTINIB, |
||||
| 21 | 26559518 |
JP |
70 | 1 |
Renal impairment, Myelosuppression, Rash, Wrong technique in product usage process, Therapy cessation, |
||||
BEMPEDOIC ACID, EZETIMIBE, ROSUVASTATIN, ROSUVASTATIN, |
||||
| 22 | 26559633 |
CN |
70 | 2 |
Disease progression, Myelosuppression, Pneumonia, Aspergillus infection, Influenza, |
||||
DOXORUBICIN, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, |
||||
| 23 | 26559650 |
CN |
72 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, BEVACIZUMAB, CAPECITABINE, |
||||
| 24 | 26559876 |
CN |
44 | 2 |
Myelosuppression, |
||||
| 25 | 26559909 |
CN |
58 | 2 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 26 | 26560090 |
CN |
43 | 2 |
Myelosuppression, Tuberculosis, Poverty of speech, Dyschezia, Anger, Tongue coated, Night sweats, Depression, Emotional distress, Irritability, Anxiety, Dry mouth, Liver disorder, Asplenia, Hot flush, Fatigue, Asthenia, Initial insomnia, Constipation, Decreased appetite, Nausea, Vomiting, Palpitations, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, PERTUZUMAB, PERTUZUMAB, |
||||
| 27 | 26560486 |
CN |
71 | 1 |
Myelosuppression, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, CYTARABINE, |
||||
| 28 | 26560496 |
CN |
58 | 2 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 29 | 26560766 |
CN |
55 | 2 |
Full blood count decreased, Infection, Pyrexia, Chills, Myelosuppression, White blood cell count increased, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, WATER, STERILE WATER, STERILE WATER FOR INJECTION, MEROPENEM, CELECOXIB, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, LINEZOLID, |
||||
| 30 | 26561564 |
CN |
||
Myelosuppression, Rash, Skin wound, |
||||
AMIVANTAMAB-VMJW, |
||||
| 31 | 26561595 |
JP |
||
Myelosuppression, |
||||
DURVALUMAB, |
||||
| 32 | 26549995 |
CN |
58 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, |
||||
| 33 | 26550302 |
CN |
83 | 1 |
Myelosuppression, |
||||
DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), LENALIDOMIDE, |
||||
| 34 | 26550382 |
CN |
74 | 1 |
Myelosuppression, Infection, |
||||
RITUXIMAB, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 35 | 26550798 |
CN |
66 | 1 |
Myelosuppression, |
||||
TRASTUZUMAB, CAPECITABINE, OXALIPLATIN, |
||||
| 36 | 26551131 |
GB |
71 | 2 |
Pulmonary embolism, Deep vein thrombosis, Myelosuppression, Off label use, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, DURVALUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, DURVALUMAB, CISPLATIN, |
||||
| 37 | 26551343 |
CN |
10 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MERCAPTOPURINE, CYTARABINE, |
||||
| 38 | 26551344 |
CN |
10 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MERCAPTOPURINE, CYTARABINE, |
||||
| 39 | 26551478 |
CN |
63 | 2 |
Myelosuppression, Cardiac failure, Oedema peripheral, Electrocardiogram QT prolonged, Platelet count decreased, |
||||
CLOPIDOGREL, OSIMERTINIB, |
||||
| 40 | 26551481 |
JP |
6 | 1 |
Escherichia sepsis, Enteritis infectious, Pathogen resistance, Disseminated mucormycosis, Septic shock, Multiple organ dysfunction syndrome, Pulmonary mucormycosis, Gastrointestinal mucormycosis, Mucormycosis, Cytomegalovirus infection, Myelosuppression, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, RITUXIMAB, METHYLPREDNISOLONE, MICAFUNGIN, MICAFUNGIN SODIUM, METHYLPREDNISOLONE, |
||||
| 41 | 26551538 |
CN |
54 | 1 |
Myelosuppression, |
||||
ATEZOLIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 42 | 26551635 |
VN |
1 | |
Myelosuppression, Pneumonia, Respiratory distress, Condition aggravated, Anaemia, Otitis media, Thrombocytopenia, Off label use, |
||||
GANCICLOVIR SODIUM, GANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, AMPICILLIN, AMPICILLIN SODIUM, AMPICILLIN INJECTION, GENTAMICIN, GENTAMICIN SULFATE, CEFOTAXIME, CEFOTAXIME INJECTION, ACYCLOVIR, MEROPENEM, |
||||
| 43 | 26551808 |
71 | 2 | |
Pneumonia, Myelosuppression, Leukopenia, Thrombocytopenia, Neoplasm progression, Aspergillus infection, Influenza, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DOXORUBICIN, DOXORUBICIN, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 44 | 26551976 |
CN |
||
Infection, Myelosuppression, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 45 | 26552116 |
JP |
7 | 2 |
Myelosuppression, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 46 | 26552341 |
76 | 2 | |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, |
||||
| 47 | 26552765 |
58 | 1 | |
Myelosuppression, |
||||
CETUXIMAB, IRINOTECAN HYDROCHLORIDE, |
||||
| 48 | 26554238 |
US |
2 | 2 |
Myelosuppression, Photosensitivity reaction, Drug ineffective, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, RIFAMPIN, RIFAMPIN, RIFABUTIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 49 | 26554274 |
CN |
83 | 1 |
Myelosuppression, |
||||
FRUQUINTINIB, |
||||
| 50 | 26554952 |
JP |
73 | 1 |
Differentiation syndrome, Electrocardiogram QT prolonged, Electrocardiogram QT prolonged, Electrocardiogram QT prolonged, Electrocardiogram QT prolonged, Electrocardiogram QT prolonged, Electrocardiogram QT prolonged, Electrocardiogram QT prolonged, Electrocardiogram QT prolonged, Electrocardiogram QT prolonged, Electrocardiogram QT prolonged, Electrocardiogram QT prolonged, Electrocardiogram QT prolonged, Myelosuppression, Sialoadenitis, Pneumonia fungal, |
||||
IVOSIDENIB, IVOSIDENIB, IVOSIDENIB, IVOSIDENIB, IVOSIDENIB, IVOSIDENIB, IVOSIDENIB, IVOSIDENIB, IVOSIDENIB, IVOSIDENIB, IVOSIDENIB, IVOSIDENIB, IVOSIDENIB, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, ITRACONAZOLE, ITRACONAZOLE, MICAFUNGIN SODIUM, CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE, MEROPENEM, MEROPENEM, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, ACYCLOVIR, ACYCLOVIR, |
||||
| 51 | 26555182 |
CN |
39 | 2 |
Myelosuppression, Pyrexia, Petechiae, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, STERILE WATER FOR INJECTION, CYTARABINE, CYTARABINE, CYTARABINE, CYTARABINE, CYTARABINE, GILTERITINIB, |
||||
| 52 | 26555202 |
CN |
62 | 1 |
Myelosuppression, |
||||
ZANUBRUTINIB, OBINUTUZUMAB, LENALIDOMIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 53 | 26555291 |
CN |
48 | 1 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, STERILE WATER FOR INJECTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 54 | 26548913 |
EU |
48 | 2 |
Leukopenia, Myelosuppression, Condition aggravated, |
||||
VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 55 | 26548999 |
CN |
58 | 2 |
Myelosuppression, Asthenia, |
||||
RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 56 | 26549021 |
CN |
74 | 1 |
Myelosuppression, Overdose, Off label use, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, |
||||
| 57 | 26549108 |
CN |
42 | 1 |
Myelosuppression, Therapy partial responder, |
||||
POLATUZUMAB VEDOTIN, |
||||
| 58 | 26549350 |
CN |
57 | 1 |
Myelosuppression, |
||||
TRASTUZUMAB, PERTUZUMAB, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 59 | 26549817 |
CN |
70 | 1 |
Myelosuppression, Full blood count decreased, Sepsis, Procalcitonin decreased, Granulocyte count decreased, Anaemia, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, CYTARABINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, STERILE WATER FOR INJECTION, |
||||
| 60 | 26549830 |
CN |
55 | 2 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), BEVACIZUMAB, BEVACIZUMAB, |
||||
| 61 | 26549842 |
CN |
41 | 1 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, |
||||
| 62 | 26549850 |
CN |
70 | 2 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 63 | 26549858 |
CN |
51 | 1 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 64 | 26549859 |
CN |
55 | 1 |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 65 | 26549863 |
CN |
56 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 66 | 26549877 |
CN |
55 | 2 |
Myelosuppression, |
||||
| 67 | 26549884 |
CN |
68 | 1 |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 68 | 26549937 |
CN |
||
Myelosuppression, Back pain, Drug intolerance, General physical condition abnormal, |
||||
AMIVANTAMAB-VMJW, |
||||
| 69 | 26549943 |
CN |
47 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 70 | 26549958 |
CN |
54 | |
Off label use, Myelosuppression, |
||||
TRASTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 71 | 26549976 |
CN |
75 | 2 |
Myelosuppression, |
||||
DARATUMUMAB, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 72 | 26547021 |
CN |
65 | 2 |
Myelosuppression, Hyperpyrexia, |
||||
PERTUZUMAB, TRASTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 73 | 26547631 |
CN |
75 | 2 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 74 | 26547865 |
CN |
80 | 1 |
Myelosuppression, |
||||
VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, DEXTROSE MONOHYDRATE, DEXTROSE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, |
||||
| 75 | 26548323 |
CN |
51 | 2 |
Myelosuppression, |
||||
VENETOCLAX, CYTARABINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 76 | 26542637 |
CN |
55 | 2 |
Myelosuppression, |
||||
RITUXIMAB, RITUXIMAB, |
||||
| 77 | 26542649 |
CN |
68 | 2 |
Neutrophil count decreased, Myelosuppression, White blood cell count decreased, |
||||
TRASTUZUMAB, PERTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, TRASTUZUMAB, TRASTUZUMAB, PERTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 78 | 26542695 |
CN |
50 | 2 |
Myelosuppression, |
||||
PEMETREXED DISODIUM, PEMETREXED DISODIUM, CISPLATIN, CISPLATIN, |
||||
| 79 | 26542741 |
CN |
66 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, TRASTUZUMAB, |
||||
| 80 | 26542746 |
CN |
68 | 2 |
Myelosuppression, |
||||
OXALIPLATIN, OXALIPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 81 | 26542881 |
JP |
3 | 2 |
Myelosuppression, Renal impairment, Hepatic function abnormal, |
||||
PAZOPANIB HYDROCHLORIDE, |
||||
| 82 | 26542912 |
CN |
26 | 2 |
Myelosuppression, Haemoglobin decreased, White blood cell count decreased, Platelet count decreased, |
||||
VENETOCLAX, CLADRIBINE, CYTARABINE, |
||||
| 83 | 26542943 |
CN |
70 | 2 |
Myelosuppression, |
||||
VENETOCLAX, |
||||
| 84 | 26542974 |
2 | ||
Myelosuppression, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 85 | 26543218 |
CN |
70 | 2 |
Acute respiratory failure, Adenocarcinoma gastric, Disease progression, Myelosuppression, Leukopenia, Thrombocytopenia, Aspergillus infection, Influenza, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, DOXORUBICIN, PREDNISONE, |
||||
| 86 | 26543237 |
CN |
70 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, |
||||
| 87 | 26543323 |
CN |
71 | 1 |
Pyrexia, Myelosuppression, |
||||
VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, |
||||
| 88 | 26543672 |
CN |
73 | 2 |
White blood cell count decreased, Neutrophil count decreased, Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 89 | 26543696 |
60 | 2 | |
Myelosuppression, Neutrophil count decreased, |
||||
DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 90 | 26543711 |
CN |
70 | 2 |
Acute respiratory failure, Adenocarcinoma gastric, Disease progression, Myelosuppression, Leukopenia, Thrombocytopenia, Aspergillus infection, Influenza, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, DOXORUBICIN, PREDNISONE, |
||||
| 91 | 26543754 |
CN |
67 | 2 |
Myelosuppression, |
||||
| 92 | 26543846 |
CN |
38 | 2 |
White blood cell count decreased, Neutrophil count decreased, Myelosuppression, |
||||
PERTUZUMAB, CARBOPLATIN, TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 93 | 26544171 |
CN |
69 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TRASTUZUMAB, |
||||
| 94 | 26544305 |
CN |
58 | 2 |
Myelosuppression, Off label use, |
||||
BEVACIZUMAB, CARBOPLATIN, IFOSFAMIDE, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 95 | 26544433 |
CN |
60 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 96 | 26544728 |
CN |
49 | 2 |
Myelosuppression, Blood potassium decreased, Blood albumin decreased, Blood sodium decreased, Calcium ionised decreased, Product use issue, Blood chloride decreased, Protein total decreased, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 97 | 26545202 |
CN |
64 | 2 |
Myelosuppression, Off label use, |
||||
ABEMACICLIB, |
||||
| 98 | 26545384 |
CN |
63 | 1 |
Myelosuppression, Granulocyte count decreased, Sepsis, Intestinal obstruction, Faecalith, Acute abdomen, |
||||
CYTARABINE, AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, VENETOCLAX, VENETOCLAX, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, WATER, STERILE WATER, STERILE WATER FOR INJECTION, |
||||
| 99 | 26545460 |
CN |
14 | 1 |
Myelosuppression, |
||||
METHOTREXATE SODIUM, MERCAPTOPURINE, VINCRISTINE SULFATE, |
||||
| 100 | 26545467 |
CN |
43 | 1 |
Myelosuppression, Pyrexia, Arthralgia, Pain in extremity, Dizziness, Asthenia, Sepsis, |
||||
CYTARABINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28